Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA64390
Max Phase: Preclinical
Molecular Formula: C24H36N2O3S
Molecular Weight: 432.63
Molecule Type: Small molecule
Associated Items:
ID: ALA64390
Max Phase: Preclinical
Molecular Formula: C24H36N2O3S
Molecular Weight: 432.63
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCO[C@H]1CC[C@@](CS)(C(=O)N[C@@H](Cc2ccccc2)C(=O)NC2CCCC2)CC1
Standard InChI: InChI=1S/C24H36N2O3S/c1-2-29-20-12-14-24(17-30,15-13-20)23(28)26-21(16-18-8-4-3-5-9-18)22(27)25-19-10-6-7-11-19/h3-5,8-9,19-21,30H,2,6-7,10-17H2,1H3,(H,25,27)(H,26,28)/t20-,21-,24+/m0/s1
Standard InChI Key: KKIOBDXUQCQOTL-AWRGLXIESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 432.63 | Molecular Weight (Monoisotopic): 432.2447 | AlogP: 3.67 | #Rotatable Bonds: 9 |
Polar Surface Area: 67.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.06 | CX Basic pKa: | CX LogP: 3.92 | CX LogD: 3.92 |
Aromatic Rings: 1 | Heavy Atoms: 30 | QED Weighted: 0.52 | Np Likeness Score: -0.31 |
1. Fink CA, Carlson JE, Boehm C, McTaggart P, Qiao Y, Doughty J, Ganu V, Melton R, Goldberg R.. (1999) Design and synthesis of thiol containing inhibitors of matrix metalloproteinases., 9 (2): [PMID:10021927] [10.1016/s0960-894x(98)00716-1] |
Source(1):